KALV - KalVista Pharmaceuticals Inc
12.25
-0.200 -1.633%
Share volume: 403,050
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$12.45
-0.20
-0.02%
Summary score
49%
Profitability
43%
Dept financing
4%
Liquidity
58%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2021 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.16%
Return on assets
-22.59%
Return on sales
0%
Return on invested capital
356.82%
Total debt ratio
15.29%
Debt ratio change over timeo
-0.73%
Current Ratio
8.07%
Quick Ratio
9.59%
Cash Position Ratio
2.72%
Short-term ratios 30-Jun-2024 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-22.59%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
14.21%
Debt ratio change over timeo
-0.97%
Current Ratio
8.44%
Quick Ratio
0%
Cash Position Ratio
1.56%
Last quarter ratios 30-Jun-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.12%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
16.69%
Debt ratio change over time
0%
Current Ratio
6.87%
Quick Ratio
0%
Cash Position Ratio
1.88%
Performance ratios (change over 4 years) 30-Jun-2021 - 30-Jun-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-175.84%
Return on assets
-145%
Return on sales
0%
Return on invested capital
1477.25%
Total debt ratio
-72.78%
Debt ratio change over time
-0.73%
Current Ratio
21.58%
Quick Ratio
41.39%
Cash Position Ratio
16.26%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KALV | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -17.16% | 14.81% | 0% | 0% |
| Return on assets | -22.59% | 4.35% | 0% | 0% |
| Return on sales | 0% | 28.69% | 0% | 0% |
| Return on invested capital | 356.82% | 10.07% | 0% | 0% |
| Profitability | 25% | 76% | 0% | 0% |
| Total debt ratio | 15.29% | 80.77% | 0% | 0% |
| Debt ratio change over time | -0.73% | -19.16% | 0% | 0% |
| Dept financing | 5% | 25% | 25% | 0% |
| Current Ratio | 8.44% | 1.21% | 0% | 0% |
| Quick Ratio | 0% | 0.93% | 0% | 0% |
| Cash Position Ratio | 1.56% | 0.13% | 0% | 0% |
| Liquididy | 75% | 7% | 0% | 0% |
| Short-term ratios | KALV | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -22.59% | 4.25% | 0% | 0% |
| Return on sales | 0% | 25.7% | 0% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 0% | 0% |
| Total debt ratio | 14.21% | 81.57% | 0% | 0% |
| Debt ratio change over time | -0.97% | 6.29% | 0% | 0% |
| Dept financing | 4% | 50% | 0% | 0% |
| Current Ratio | 8.44% | 1.21% | 0% | 0% |
| Quick Ratio | 0% | 0.93% | 0% | 0% |
| Cash Position Ratio | 1.56% | 0.13% | 0% | 0% |
| Liquididy | 50% | 31% | 0% | 0% |